Using Robotics in Laboratories During the COVID-19 Outbreak with Andrew Alliance
The clinical and analytical laboratory has been at the forefront of the fight against the COVID-19 pandemic. This is where testing is carried out, guiding hospitalization and providing information on the spread of the disease. It is also central to the development of new medicines and the vaccines that are still being tested. Laboratories make extensive use of robotics and automation to safely improve quality and productivity at an acceptable cost. Join Nigel Skinner from the Andrew Alliance as he discussed their IEEE Review.
Scaling Beyond COVID Rapid Testing with BioDot
COVID is still a testing challenge for citizens, businesses, and entire countries. The pandemic afforded us (the healthcare community) the opportunity to improve processes, and most importantly to advance science. The regulatory process has streamlined approvals for testing, both in the tests used and in the labs that can perform the tests, but due the magnitude of testing, simplification and economics in testing became key drivers, and this is where rapid test technology shines. Point-of-Care (POC) Over the Counter (OTC) tests are now approved for COVID and there will be more to follow, likely in other infectious disease areas. Beyond COVID, we see a medicine cabinet filled will home tests for Influenza, Streptococcus, Pneumonia, all connected via mobile devices to your physician via telemedicine. If results are negative, only then do you proceed to Urgent Care. The applications reach far beyond infectious disease - think about food allergies. How many of us have nut, dairy, gluten or seafood allergies? When venturing out to a restaurant and verifying with the server that the food is allergy-free, would we not want to have our own portable rapid test in hand to confirm that it actually is a gluten-free dish before we indulge? The point here is COVID was the door opener to simplified, affordable testing which puts the testing device in the hands of the patient and consumer. The next step is to consider how to develop these rapid tests and how these tests can be produced at scale. Join BioDot as it shares its lateral flow test scaling for COVID.
This program is FREE.